A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53
Division of Experimental Therapeutics, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2M9, Canada.